ClinicalTrials.Veeva

Menu

Gender Specific Differences in Postoperative Sore Throat for Ambu® AuraGain™ Laryngeal Mask (LadyLAMA)

J

Johannes Gutenberg University (JGU)

Status

Completed

Conditions

Postoperative Pain
Postoperative Complications

Treatments

Device: Ambu® AuraGain™ Laryngeal Mask (LM)

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate gender specific risk factors and the influence of cuff pressure in the occurrence of postoperative sore throat and hoarseness following general anaesthesia using Ambu® AuraGain™ Laryngeal Mask.

Full description

The history and physical examinations of all patients scheduled for surgery are screened preoperatively for exclusion criteria. Patient recruitment is conducted by one of the study physicians. After eligibility is confirmed and written informed consent is obtained, enrolled participants are randomized depending on their gender (400 men, 400 women) in a single-blinded manner (patients) 24 hours before the intervention in a 1:1 ratio to low cuff pressure (45 cmH2O) or normal cuff pressure (60 cmH2O). Patient questioning via questionnaire is conducted in postoperative anaesthetic care unit, 24h, 48h and 72h until freedom of symptoms.

Enrollment

814 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • elective surgery in ophthalmology under general anaesthesia with laryngeal mask
  • Age > 18
  • informed written consent

Exclusion criteria

  • Anticipated difficult airway with indication for awake tracheal intubation
  • Indication for RSI or elevated risk for aspiration;
  • Pregnant or breastfeeding;
  • Age < 18 years;
  • Obesity
  • Out-patient surgery (Geb. 505);
  • Limited mouth opening;
  • Pre-existing hoarseness and sore throat
  • Participant in other studies
  • Unable to provide informed written consent or under guardianship

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

Single Blind

814 participants in 4 patient groups

Women - low cuff pressure
Other group
Description:
A cuff pressure of 45 cm H2O is used to block the laryngeal mask
Treatment:
Device: Ambu® AuraGain™ Laryngeal Mask (LM)
Men - low cuff pressure
Other group
Description:
A cuff pressure of 45 cm H2O is used to block the laryngeal mask
Treatment:
Device: Ambu® AuraGain™ Laryngeal Mask (LM)
Women - normal cuff pressure
Other group
Description:
A cuff pressure of 60 cm H2O is used to block the laryngeal mask
Treatment:
Device: Ambu® AuraGain™ Laryngeal Mask (LM)
Men - normal cuff pressure
Other group
Description:
A cuff pressure of 60 cm H2O is used to block the laryngeal mask
Treatment:
Device: Ambu® AuraGain™ Laryngeal Mask (LM)

Trial contacts and locations

1

Loading...

Central trial contact

Katharina Epp, MD; Nina Pirlich, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems